VERACYTE, INC. Quarterly Income Tax Expense (Benefit) in USD from Q2 2019 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Veracyte, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2019 to Q2 2024.
- Veracyte, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $1.63M, a 1202% increase year-over-year.
- Veracyte, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$750K, a 299% decline year-over-year.
- Veracyte, Inc. annual Income Tax Expense (Benefit) for 2023 was -$2.21M, a 1760% decline from 2022.
- Veracyte, Inc. annual Income Tax Expense (Benefit) for 2022 was $133K.
- Veracyte, Inc. annual Income Tax Expense (Benefit) for 2021 was -$6.09M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)